Skip to main content
OpenTrials
Completed

NCT Number: NCT05357742

Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease

The overarching goal of this proposal is to test the feasibility of a basic needs navigation intervention on improving clinical outcomes, self-care behaviors and quality of life in low-income African Americans with diabetic kidney disease (DKD) experiencing multidimensional adversity.

The study objective will be achieved with the following aims:

Aim 1: To determine the feasibility of a basic needs navigation intervention as measured by recruitment, session attendance and retention in low-income Africans Americans with DKD experiencing multidimensional adversity.

Aim 2: To determine the frequency and compounding nature of different basic needs in Africans Americans with DKD experiencing multidimensional adversity to help refine the basic needs navigation intervention.

Aim 3: To evaluate the change and variability in the clinical outcomes (hemoglobin A1c, blood pressure, lipids) at 6 months of follow-up to plan for larger trial.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Multidimensional adversity, defined as having three or more social adversities such as housing instability, food insecurity, transportation needs, utility needs, interpersonal safety, and financial strain impacts the complex self-management of DKD and negatively impacts health outcomes. Evidence suggests patient navigation programs may be a promising strategy to improve health outcomes in low-income individuals with chronic disease. However, there is limited evidence on the use of patient navigator programs to address multidimensional adversity in individuals with chronic disease. Therefore, the primary objective of this study is to address this gap in knowledge.

Study overview: This will be accomplished using a two-arm pilot randomized control trial. Fifty (50) African American adults with DKD experiencing multidimensional adversity will be randomized into one of two arms: 1) Intervention arm and 2) Enhanced usual care arm.

Description of intervention: Participants randomized to the intervention arm will receive the manualized study intervention which includes three components 1) DKD education, 2) Individualized basic needs navigation, and 3) Lifestyle coaching and skills training. Participants will be provided a FORA 2-in-1 device with glucose test strips to allow testing at least once a day. The device automatically uploads blood pressure and glucose readings to a secure server in real time and the health educator will have access to this secure server. Readings will be used to guide lifestyle coaching and skills training. All participants will be assessed at baseline, 3- and 6-months for clinical outcomes (hemoglobin A1c, blood pressure, lipids), self-care behaviors (diet, exercise, and medication adherence), and quality of life (SF-12).

Control arm (Enhanced usual care arm): Participants randomized to the control arm will receive the manualized study intervention which incudes only DKD education.

All participants will be assessed at baseline, 3- and 6-months for clinical outcomes (hemoglobin A1c, blood pressure, lipids), self-care behaviors (diet, exercise, and medication adherence), and quality of life (SF-12).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • self- report as Black/African American
  • age ≥18
  • screen positive for 1 or more adversities using the Centers for Medicare and Medicaid Services Accountable Health Communities Health-Related Social Needs Screening tool
  • diagnosed type 2 diabetes (T2DM) with HbA1c≥8
  • chronic kidney disease (CKD)
  • able to communicate in English.

Exclusion criteria

  • does not identify as Black/African American
  • age <18
  • no diagnosis of T2DM and CKD
  • cognitive impairment at screening visit
  • active psychosis
  • active alcohol or drug abuse/dependency
  • life expectancy <12 months
  • participation in other diabetes/CKD trials
  • unable to communicate in English.

Treatment and study plan

Individualized basic need navigation and lifestyle coaching and skills training

Behavioral

During each session participants will receive the manualized study intervention which includes 1) DKD education, 2) Individualized basic needs navigation, and 3) Lifestyle coaching and skills training. Participants will be provided a FORA 2-in-1 device with glucose test strips to allow testing at least once a day. The device automatically uploads blood pressure and glucose readings to a secure server in real time and the health educator will have access to this secure server. Readings will be used to guide lifestyle coaching and skills training.

Enhanced Usual Care

Behavioral

During each session participants will receive DKD education only.

Primary outcomes

  1. Feasibility of the basic needs navigation intervention

    Time frame: At 6 months post intervention follow-up

    Feasibility of the basic needs navigation intervention as measured by recruitment, session attendance and retention

Secondary outcomes

  1. Basic Needs

    Time frame: At 6 months post intervention follow-up

    Frequency of basic needs will be assessed using the Centers for Medicare and Medicaid Services Accountable Health Communities Health-Related Social Needs Screening tool

  2. Hemoglobin A1c (Hb A1c)

    Time frame: Change in baseline Hb A1c at 6 months post intervention follow-up

    Blood will be drawn by trained phlebotomist for HbA1c

  3. Systolic blood pressure (SBP)

    Time frame: Change in baseline SBP at 6 months post intervention follow-up

    Blood pressure readings will be obtained using automated BP monitors (OMRON IntelliSenseTM HEM-907XL)

  4. LDL cholesterol

    Time frame: Change in baseline LDL at 6 months post intervention follow-up

    Blood sample will be drawn by a trained phlebotomist and sent to the laboratory for LDL cholesterol.

Sponsors and collaborators

Lead sponsor

Medical College of Wisconsin

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
May 3, 2022
Registry last updated
Dec 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.